<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00539565</url>
  </required_header>
  <id_info>
    <org_study_id>KCH99LG21</org_study_id>
    <nct_id>NCT00539565</nct_id>
  </id_info>
  <brief_title>RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.</brief_title>
  <official_title>Phase IIIb Study of Corticosteroids as Post-Operative Adjuvant Therapy in Biliary Atresia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King's College Hospital NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biliary atresia is a congenital disorder of bile duct development or destruction of&#xD;
      established but immature bile ducts. The study tests the hypothesis that post-operative&#xD;
      steroids improve outcome following the Kasai procedure - the commonest surgical treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biliary atresia is a potentially fatal condition of infants presenting as persisting jaundice&#xD;
      in the first few weeks of life. The disease is characterised by obstruction and damage to the&#xD;
      intra and extrahepatic parts of the biliary tree. Within the liver there is also a pronounced&#xD;
      inflammatory response. The initial treatment is an attempt, by surgery, to restore bile flow&#xD;
      by excising the obliterated extrahepatic bile ducts and joining part of the intestine to the&#xD;
      bile &quot;root&quot; of the liver (the porta hepatis). This is known as the Kasai procedure. This is&#xD;
      successful in ~50% of cases in reducing the level of jaundice to near-normal values. The use&#xD;
      of steroids post-operatively has been suggested as improving outcome by diminishing the&#xD;
      inflammatory response.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>January 2000</start_date>
  <completion_date type="Anticipated">September 2008</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clearance of jaundice (&lt;20 umol/L)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion transplanted or died</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>biochemical indices of liver function</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Biliary Atresia</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral corticosteroids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>as for active regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prednisolone</intervention_name>
    <description>2 mg/kg /day from post-op day 7 - day 21&#xD;
1 mg/kg /day from post-op day 22 - day 30</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  biliary atresia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;100 days at portoenterostomy&#xD;
&#xD;
          -  no other anomalies (e.g. Biliary Atresia Splenic Malformation syndrome)&#xD;
&#xD;
          -  anu contra-indications to corticosteroids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Davenport, ChM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kings College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <study_first_submitted>October 3, 2007</study_first_submitted>
  <study_first_submitted_qc>October 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2007</study_first_posted>
  <last_update_submitted>October 3, 2007</last_update_submitted>
  <last_update_submitted_qc>October 3, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 4, 2007</last_update_posted>
  <keyword>biliary atresia</keyword>
  <keyword>Kasai portoenterostomy</keyword>
  <keyword>corticosteroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

